Lenvanix 4mg Capsule 30's (Lenvanitib)

Lenvanix 4mg Capsule is used for differentiated thyroid cancer, advanced renal cell carcinoma, and unresectable liver cancer. Doctors prescribe it for adults with progressive or advanced tumours.

Lenvanix 4mg Capsule Ingredients and Usage

Lenvanix 4mg Capsule contains lenvatinib, a multikinase inhibitor used in targeted cancer therapy. A multikinase inhibitor is a drug that blocks several tumour growth signals at once. Doctors prescribe Lenvanix for adults with specific advanced cancers.

Lenvanix 4mg Capsule treats radioactive iodine refractory differentiated thyroid cancer as a single agent therapy. It also treats advanced renal cell carcinoma when combined with everolimus after prior antiangiogenic treatment. Lenvanix serves as first line therapy for unresectable hepatocellular carcinoma, a primary liver cancer.

How Does Lenvanix 4mg Capsule Work?

Lenvanix 4mg Capsule blocks receptor tyrosine kinases, the enzymes that drive tumour blood vessel growth. Lenvatinib inhibits VEGFR 1, 2, and 3, the vascular endothelial growth factor receptors that fuel angiogenesis. Angiogenesis is the formation of new blood vessels that supply oxygen to tumours.

Lenvanix also inhibits FGFR 1 to 4, PDGFR alpha, RET, and KIT receptors. These targets stop cancer cells from proliferating and starve the tumour of its blood supply. This dual action shrinks tumours and slows cancer progression.

Lenvanix 4mg Capsule Side Effects

Lenvanix 4mg Capsule causes side effects common to VEGF targeted therapies. Most patients experience high blood pressure, fatigue, and digestive problems during treatment.

• High blood pressure (hypertension)

• Diarrhoea and nausea

• Decreased appetite and weight loss

• Fatigue or weakness

• Joint and muscle pain

• Dry mouth, hoarseness, and nosebleeds

• Protein in the urine (proteinuria)

• Hand foot skin reaction

Warnings

• Lenvanix can cause serious and fatal cardiac dysfunction, including heart failure. Doctors monitor patients for signs of cardiac decompensation.

• Lenvanix raises the risk of severe or fatal hemorrhagic events. Patients with tumour invasion of major blood vessels face higher bleeding risk.

• Lenvanix prolongs the QT interval, a heart rhythm measure linked to dangerous arrhythmias. Avoid combining it with other QT prolonging drugs.

• Lenvanix causes embryo fetal harm and is contraindicated in pregnancy. Women of reproductive age must use effective contraception during treatment.

• Lenvanix can cause hepatotoxicity, renal failure, and gastrointestinal perforation. Patients need regular liver, kidney, and blood pressure monitoring.

Lenvanix 4mg Capsule Storage Conditions

Store Lenvanix 4mg Capsule at room temperature between 15°C and 30°C in its original container. Keep the capsules in the sealed child resistant pot to protect them from moisture and humidity. Store away from direct sunlight and heat, and keep Lenvanix out of the reach of children.